These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1037363)

  • 1. [Results of CB 154 in the treatment of acromegaly in France (author's transl)(proceedings)].
    Bricaire H
    Ann Endocrinol (Paris); 1976; 37(4):305-8. PubMed ID: 1037363
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of acromegaly by dibromoergocryptine and cyproheptadine (author's transl)(proceedings)].
    Mornex R; Berthezene F; Claustrat B; Fischer C
    Ann Endocrinol (Paris); 1976; 37(4):303-4. PubMed ID: 1037362
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bromocriptine therapy in acromegaly (author's transl)(proceedings)].
    Schaison G; Mowszowicz I
    Ann Endocrinol (Paris); 1976; 37(4):297-8. PubMed ID: 1037359
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutical effects of bromocriptine in 10 acromegalic patients: study of somatotrophic function and glucose tolerance test (author's transl)(proceedings)].
    Fossati P; Asfour M; Brion-Brevan B; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA
    Ann Endocrinol (Paris); 1976; 37(4):299-300. PubMed ID: 1037360
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bromocriptin treatment of acromegaly (author's transl)(proceedings)].
    Bricaire H; Strauch G; Boutonnat Y
    Ann Endocrinol (Paris); 1976; 37(4):301-2. PubMed ID: 1037361
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fall of the growth hormone levels in acromegalics after bromocryptin (author's transl)].
    Dolecek R
    Cas Lek Cesk; 1976 Aug; 115(33-34):1056-7. PubMed ID: 989744
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutical effects of bromocriptine (CB 154) in 10 acromegalic subjects. Study of somatotrophic function and clinical survey (author's transl)].
    Fossati P; Asfour M; Brion-Brevan B; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA; Blacker C
    Ann Endocrinol (Paris); 1977; 38(4):291-301. PubMed ID: 332054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of acromegaly using bromocriptine].
    Köbberling J; Schwinn G; Dirks H
    Dtsch Med Wochenschr; 1975 Jul; 100(29):1540-2. PubMed ID: 1149634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical use of CB-154 in acromegaly (author's transl)].
    Demura R
    Horumon To Rinsho; 1979 May; 27(5):495-504. PubMed ID: 455758
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of acromegaly with bromocryptine.
    Summers VK; Hipkin LJ; Diver MH; Davis JC
    J Clin Endocrinol Metab; 1975 May; 40(5):904-6. PubMed ID: 1127097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V; Nedvídková J
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of dopaminergic stimulation on growth hormone and prolactin in the treatment of acromegaly].
    Nedvídková J; Felt V
    Vnitr Lek; 1980 Oct; 26(10):988-93. PubMed ID: 7467150
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
    Benker G; Zäh W; Hackenberg K; Hamburger B; Günnewig H; Reinwein D
    Horm Metab Res; 1976 Jul; 8(4):291-5. PubMed ID: 182633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine therapy in acromegaly.
    Sachdev Y; Gomez-Pan A; Tunbridge WM; Duns A; Weightman DR; Hall R; Goolamali SK
    Lancet; 1975 Dec; 2(7946):1164-8. PubMed ID: 53655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum growth hormone response to bromocriptine during a glucose tolerance test in acromegaly.
    Cassar J; Mashiter K; Sullivan G; Joplin GF
    Acta Endocrinol (Copenh); 1976 May; 82(1):39-46. PubMed ID: 946714
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patients.
    Chiodini PG; Liuzzi A; Muller EE; Botalla L; Cremascoli G; Oppizzi G; Verde G; Silvestrini F
    J Clin Endocrinol Metab; 1976 Aug; 43(2):356-63. PubMed ID: 950367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between suppression of growth hormone by CB-154 and prolactin secretion in acromegaly--indication for a long term care].
    Hara I; Kataoka K; Tomita A; Kuwayama A; Kageyama N
    Horumon To Rinsho; 1977 Dec; 25(12):1316-20. PubMed ID: 413675
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hyperprolactinemia and acromegaly with lisuride].
    Berezin M; Elchalal U; Olchovsky D
    Harefuah; 1989 Jun; 116(12):634-7. PubMed ID: 2792946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegaly.
    Dallabonzana D; Liuzzi A; Oppizzi G; Verde G; Chiodini PG; Dorow R; Horowski R
    J Endocrinol Invest; 1985 Apr; 8(2):147-51. PubMed ID: 4031381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of acromegaly with bromocriptine.
    Thorner MO; Besser GM
    Postgrad Med J; 1976; 52suppl 1():71-4. PubMed ID: 959128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.